Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus
J. Clin. Invest. Carlo Colombo, et al. 118:2148
doi:10.1172/JCI33777 [Go to this article.]

Figure 5
Viability of transfected INS-1E cells. Shown is the viability of INS-1E cells at 48 and 96 h after transfection with WT human (pro)insulin, hAkita mutation, human familial hyper(pro)insulinemia mutation R65L, and human MDI mutations R65C, CA6Y, LB15YB16delinsH, LB6P, LB11P, and YA19X. Human (pro)insulin was detected by monoclonal antibody directed toward the human C-peptide and C terminus of the B-chain of the (pro)insulin molecule. Few (LB6P and LB11P) or no (hAkita, R65C, CA6Y, LB15YB16delinsH, and YA19X) INS-1E cells expressing MDI mutations were visible 96 h after transfection.